Who makes Scopolamine and naltrexone?

Scopolamine and naltrexone is developed by The Taub Group.

What development phase is Scopolamine and naltrexone in?

Scopolamine and naltrexone is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Scopolamine and naltrexone

The Taub Group · FDA-approved active Small molecule Quality 2/100

At a glance

Generic name	Scopolamine and naltrexone
Sponsor	The Taub Group
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

The Safety and Efficacy of Naltrexone and Scopolamine Utilized in the Treatment of Major Depression (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Scopolamine and naltrexone CI brief — competitive landscape report
Scopolamine and naltrexone updates RSS · CI watch RSS
The Taub Group portfolio CI